pyrrolidine dithiocarbamate has been researched along with Inflammatory Bowel Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kamiie, K; Kidachi, Y; Lohning, A; Ryoyama, K; Sasaki, K; Yamaguchi, H | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Inflammatory Bowel Diseases
Article | Year |
---|---|
6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dextran Sulfate; Down-Regulation; Female; Glycogen Synthase Kinase 3 beta; Humans; Inflammatory Bowel Diseases; Interleukin-6; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction; Up-Regulation; Wasabia | 2021 |